A Big Change Is Showing Up in Your QM Reports: Hybrid Long-Stay Antipsychotic Measure

A Big Change Is Showing Up in Your QM Reports: Hybrid Long-Stay Antipsychotic Measure The new Hybrid Long-Stay Antipsychotic Quality Measure is now live and visible on MDS 3.0 QM reports resulting in dramatic shifts in scoring for some facilities.   If you haven’t...

Ask Proactive – When is a Gradual Dose Reduction (GDR) required for antipsychotic and psychotropic medications in a Skilled Nursing Facility (SNF)?

Q: When is a Gradual Dose Reduction (GDR) required for antipsychotic and psychotropic medications in a Skilled Nursing Facility (SNF)?   A: For a resident who is receiving an antipsychotic, a GDR is required unless it is clinically contraindicated. An attempt to...

Compliance Risk Assessment Considerations for the New Year

Compliance Risk Assessment Considerations for the New Year   As we enter 2025, nursing home providers face many regulatory and administrative challenges. January is a good time to conduct a compliance risk assessment that considers the updated nursing facility...